Pregledni rad
Antiplatelet Therapy in Cerebrovascular Diseases
Frederic-Ivan Silconi
Puni tekst: hrvatski pdf 97 Kb
str. 77-84
preuzimanja: 1.009
citiraj
APA 6th Edition
Silconi, F. (2022). Antiplatelet Therapy in Cerebrovascular Diseases. Medicus, 31 (1 Moždani udar), 77-77. Preuzeto s https://hrcak.srce.hr/275919
MLA 8th Edition
Silconi, Frederic-Ivan. "Antiplatelet Therapy in Cerebrovascular Diseases." Medicus, vol. 31, br. 1 Moždani udar, 2022, str. 77-77. https://hrcak.srce.hr/275919. Citirano 06.10.2024.
Chicago 17th Edition
Silconi, Frederic-Ivan. "Antiplatelet Therapy in Cerebrovascular Diseases." Medicus 31, br. 1 Moždani udar (2022): 77-77. https://hrcak.srce.hr/275919
Harvard
Silconi, F. (2022). 'Antiplatelet Therapy in Cerebrovascular Diseases', Medicus, 31(1 Moždani udar), str. 77-77. Preuzeto s: https://hrcak.srce.hr/275919 (Datum pristupa: 06.10.2024.)
Vancouver
Silconi F. Antiplatelet Therapy in Cerebrovascular Diseases. Medicus [Internet]. 2022 [pristupljeno 06.10.2024.];31(1 Moždani udar):77-77. Dostupno na: https://hrcak.srce.hr/275919
IEEE
F. Silconi, "Antiplatelet Therapy in Cerebrovascular Diseases", Medicus, vol.31, br. 1 Moždani udar, str. 77-77, 2022. [Online]. Dostupno na: https://hrcak.srce.hr/275919. [Citirano: 06.10.2024.]
Puni tekst: engleski pdf 97 Kb
str. 77-77
preuzimanja: 274
citiraj
APA 6th Edition
Silconi, F. (2022). Antiplatelet Therapy in Cerebrovascular Diseases. Medicus, 31 (1 Moždani udar), 77-77. Preuzeto s https://hrcak.srce.hr/275919
MLA 8th Edition
Silconi, Frederic-Ivan. "Antiplatelet Therapy in Cerebrovascular Diseases." Medicus, vol. 31, br. 1 Moždani udar, 2022, str. 77-77. https://hrcak.srce.hr/275919. Citirano 06.10.2024.
Chicago 17th Edition
Silconi, Frederic-Ivan. "Antiplatelet Therapy in Cerebrovascular Diseases." Medicus 31, br. 1 Moždani udar (2022): 77-77. https://hrcak.srce.hr/275919
Harvard
Silconi, F. (2022). 'Antiplatelet Therapy in Cerebrovascular Diseases', Medicus, 31(1 Moždani udar), str. 77-77. Preuzeto s: https://hrcak.srce.hr/275919 (Datum pristupa: 06.10.2024.)
Vancouver
Silconi F. Antiplatelet Therapy in Cerebrovascular Diseases. Medicus [Internet]. 2022 [pristupljeno 06.10.2024.];31(1 Moždani udar):77-77. Dostupno na: https://hrcak.srce.hr/275919
IEEE
F. Silconi, "Antiplatelet Therapy in Cerebrovascular Diseases", Medicus, vol.31, br. 1 Moždani udar, str. 77-77, 2022. [Online]. Dostupno na: https://hrcak.srce.hr/275919. [Citirano: 06.10.2024.]
Sažetak
Antiplatelet therapy has been used in clinical practice for many years in patients with acute coronary syndrome, stroke or other cerebrovascular diseases. Taking in consideration the benefits of these drugs, on rare occasions they may cause life threatening complications. The use of different antithrombotic drugs has been quite confusing so there is a need to create guidelines in order to facilitate the decision-making process. Of course, in addition to the existing guidelines, it is necessary to consider the benefits and possible risk for each patient individually. Such an approach may lead to dilemmas related to each individual drug based on recommendations. This review tries to give a cross-section of the current situation in antiplatelet therapy.
Ključne riječi
stroke; antiplatelet therapy; monotherapy; dual therapy; acetylsalicylic acid; clopidogrel; ticagrelor
Hrčak ID:
275919
URI
https://hrcak.srce.hr/275919
Datum izdavanja:
2.5.2022.
Podaci na drugim jezicima:
hrvatski
Posjeta: 1.989
*